EQL Pharma AB (publ) (STO:EQL)
57.20
+1.20 (2.14%)
At close: Jan 20, 2026
EQL Pharma AB Employees
EQL Pharma AB had 22 employees as of September 30, 2025. The number of employees increased by 2 or 10.00% compared to the same quarter last year.
Employees
22
Change
2
Growth
10.00%
Revenue / Employee
18.14M SEK
Profits / Employee
1.35M SEK
Market Cap
1.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 22 | 2 | 10.00% |
| Jun 30, 2025 | 20 | -2 | -9.09% |
| Mar 31, 2025 | 21 | 0 | - |
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Sep 30, 2024 | 20 | 2 | 11.11% |
| Jun 30, 2024 | 22 | 4 | 22.22% |
| Mar 31, 2024 | 21 | 3 | 16.67% |
| Dec 31, 2023 | 19 | 6 | 46.15% |
| Sep 30, 2023 | 18 | 4 | 28.57% |
| Jun 30, 2023 | 18 | 4 | 28.57% |
| Mar 31, 2023 | 18 | 5 | 38.46% |
| Dec 31, 2022 | 13 | 2 | 18.18% |
| Sep 30, 2022 | 14 | 3 | 27.27% |
| Jun 30, 2022 | 14 | 3 | 27.27% |
| Mar 31, 2022 | 13 | 3 | 30.00% |
| Dec 31, 2021 | 11 | 1 | 10.00% |
| Sep 30, 2021 | 11 | 1 | 10.00% |
| Jun 30, 2021 | 11 | 1 | 10.00% |
| Mar 31, 2021 | 10 | 2 | 25.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 225 |
| Orexo AB | 110 |
| Enzymatica AB | 21 |
| Cinclus Pharma Holding AB | 18 |
| Nanexa AB | 13 |
| Cereno Scientific AB | 10 |
| Moberg Pharma AB | 10 |
| Enorama Pharma AB | 5 |